Ben Peacock
Head of Research at NanoFCM UK
Greater Sheffield Area
1K followers
500+ connections
Contributions
-
What do you do if you're a creative professional torn between new technology and traditional methods?
New technologies are an investment which must fit to future planned strategies. If a new technology can speed up a planned trajectory or provide novel opportunities, then this value should be estimated and balanced against upfront cost and temporary disruption. If you have teams with a talent for seeing this potential, then making use of a suppliers evaluation and testing facilities can be relatively painless and maintains innovation.
Activity
-
By providing concentrations of the mature intact virions, #nFCM data correlates with infectious titer measurements, whilst simultaneously quantifying…
By providing concentrations of the mature intact virions, #nFCM data correlates with infectious titer measurements, whilst simultaneously quantifying…
Shared by Ben Peacock
-
🔵 Nanoparticle synthesis can be broadly categorized into two main approaches: 𝗯𝗼𝘁𝘁𝗼𝗺-𝘂𝗽 𝗮𝗻𝗱 𝘁𝗼𝗽-𝗱𝗼𝘄𝗻! 🔵 𝗧𝗵𝗲…
🔵 Nanoparticle synthesis can be broadly categorized into two main approaches: 𝗯𝗼𝘁𝘁𝗼𝗺-𝘂𝗽 𝗮𝗻𝗱 𝘁𝗼𝗽-𝗱𝗼𝘄𝗻! 🔵 𝗧𝗵𝗲…
Liked by Ben Peacock
-
I am looking forward to present and discuss the “Evolving Analytical Trends for Characterization of mRNA” at the Bioprocessing Summit, August 19-22…
I am looking forward to present and discuss the “Evolving Analytical Trends for Characterization of mRNA” at the Bioprocessing Summit, August 19-22…
Liked by Ben Peacock
Experience
Education
More activity by Ben
-
Monday August 19th I will be presenting at the Bioprocessing Summit in Boston. I'm looking forward to discussing the latest trends in Analytical…
Monday August 19th I will be presenting at the Bioprocessing Summit in Boston. I'm looking forward to discussing the latest trends in Analytical…
Liked by Ben Peacock
-
🌟 Exciting news! LongEVity Bioscience is born! 🌟 The new company is a joint venture between Exosomics S.p.a and Arterra Bioscience S.p.A., a…
🌟 Exciting news! LongEVity Bioscience is born! 🌟 The new company is a joint venture between Exosomics S.p.a and Arterra Bioscience S.p.A., a…
Liked by Ben Peacock
-
#LNPs and #CDNs are emerging as powerful tools for gene delivery. A recent study investigates lipid nanoparticles (LNPs) and cell-derived…
#LNPs and #CDNs are emerging as powerful tools for gene delivery. A recent study investigates lipid nanoparticles (LNPs) and cell-derived…
Liked by Ben Peacock
-
Do not miss this opportunity! Today 18th July, 11 am (BST) #freewebinar #extracellularvesicles #nucleicacid…
Do not miss this opportunity! Today 18th July, 11 am (BST) #freewebinar #extracellularvesicles #nucleicacid…
Liked by Ben Peacock
-
Cindy Schelker, a PhD candidate in my lab (and Gerrit Borchard (he/him)'s lab) gave a great talk yesterday during the Globalisation of Pharmaceutics…
Cindy Schelker, a PhD candidate in my lab (and Gerrit Borchard (he/him)'s lab) gave a great talk yesterday during the Globalisation of Pharmaceutics…
Liked by Ben Peacock
-
After an unexpected layoff in March, I'm super blessed to begin my new role as Project Manager at Thermo Fisher Scientific's Cincinnati site. Huge…
After an unexpected layoff in March, I'm super blessed to begin my new role as Project Manager at Thermo Fisher Scientific's Cincinnati site. Huge…
Liked by Ben Peacock
-
This week there's new case-studies for me to share demonstrating the use of the NanoAnalyzer in #LNP characterization and generation of…
This week there's new case-studies for me to share demonstrating the use of the NanoAnalyzer in #LNP characterization and generation of…
Shared by Ben Peacock
-
NEW ARTICLE / I am proud and delighted to be part of the METRINO Project and to share our latest article, "Cutting-Edge Cryo-Characterisation for…
NEW ARTICLE / I am proud and delighted to be part of the METRINO Project and to share our latest article, "Cutting-Edge Cryo-Characterisation for…
Liked by Ben Peacock
-
As we are approaching the half-way mark of the Liposome Research Days 2024 congress, full of stimulating talks and engaging conversations, make sure…
As we are approaching the half-way mark of the Liposome Research Days 2024 congress, full of stimulating talks and engaging conversations, make sure…
Liked by Ben Peacock
-
Exciting news for EVIIVE (Richard Chahwan), 1st place in the Health & Nutrition vertical in the prestigious >>venture>> Startup Competition! Proud to…
Exciting news for EVIIVE (Richard Chahwan), 1st place in the Health & Nutrition vertical in the prestigious >>venture>> Startup Competition! Proud to…
Liked by Ben Peacock
-
Very happy to present my PhD project: Polymer nanoparticles as a targeted drug delivery system for the treatment of the autoimmune disease rheumatoid…
Very happy to present my PhD project: Polymer nanoparticles as a targeted drug delivery system for the treatment of the autoimmune disease rheumatoid…
Liked by Ben Peacock
-
Happy to be here and present some of our amazing work! #etpn #imm #fraunhofer
Happy to be here and present some of our amazing work! #etpn #imm #fraunhofer
Liked by Ben Peacock
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Ben Peacock in United Kingdom
-
Ben Peacock
Group CFO
-
Ben Peacock
Hedge Fund Distribution, Vice President at Morgan Stanley
-
Ben P.
Group Bars Manager For Hyde & Co Group
-
Ben Peacock
Development Chef @ Pilgrim's Food Masters | Product Development and implementation
40 others named Ben Peacock in United Kingdom are on LinkedIn
See others named Ben Peacock